Bulletin references January 2026

You can read the January 2026 Bulletin here.

Pathology solutions

How the Anthony Nolan charity is addressing haematopoietic cell transplant inequities from all angles

  1. Mayor NP, Szydlo RM, Sheikh Y, Lee J, Pearce RM, Farrow C et al. The impact of patient ethnicity on haematopoietic cell transplantation outcome: a retrospective cohort study on the UK experience. Lancet Haematol 2024;11(12):e916–e926.
  2. Leen G, Stein JE, Robinson J, Torres HM, Marsh SGE. The HLA diversity of the Anthony Nolan register. HLA 2021;97(1):15–29.
  3. Agapiou M, Natarajan RHL, Rutt C, Misra S, Robinson J, Cereb N et al. Modeling an international donor recruitment strategy in a collaborative pilot study between a UK and Indian donor registry. HLA 2024;103:62.
  4. Schmidt AH, Sauter J, Baier DM, Daiss J, Keller A, Klussmeier A et al. Immunogenetics in stem cell donor registry work: The DKMS example (Part 1). Int J Immunogenet 2020;47:13–23.
  5. Shaw BE, Mayor NP, Szydlo RM, Bultitude WP, Anthias C, Kirkland K et al. Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants. Bone Marrow Transplant 2017;5:717–725.
  6. Shaw BE, Marsh SGE, Mayor NP, Russell NH, Madrigal JA. HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants. Blood 2006;107(3):1220–1226.
  7. Al Malki MM, Bo-Subait S, Logan B, Olson J, Kou J, Smith S et al. Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis after mismatched unrelated donor peripheral blood stem cell transplantation. J Clin Oncol 2025;43:2772–2781.
  8. Office of Health Economics. The value of cell and gene therapies to the UK economy. Available at: www.ohe.org/wp-content/uploads/2025/10/Sampson-at-al.-2025-The-value-of-cell-and-gene-therapies-to-the-UK-economy-FINAL.pdf
  9. Olesko KM, Eames A, Mody CCM, Lowy I, Zeller T, Walker M et al. The crisis in American science. History Sci 2025;63(2):125–165.